{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:40:50Z","timestamp":1781134850802,"version":"3.54.1"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVE<\/jats:title>\n                  <jats:p>Methadone and morphine are commonly administered medications for neonatal opioid withdrawal syndrome (NOWS). Infants are increasingly treated with as-needed or \u201cpro re nata\u201d (PRN) medication. The optimal pharmacologic agent for PRN treatment of NOWS has not been examined. This study\u2019s objective is to compare NOWS hospital outcomes between infants treated with PRN methadone versus morphine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We performed a retrospective cohort study of infants pharmacologically treated for NOWS across 4 Massachusetts hospitals between January 2018 and February 2021. Infants born \u226536 weeks gestation with prenatal opioid exposure treated with PRN methadone or morphine were included. Mixed effects logistic and linear regression models were employed to evaluate differences in transition rates to scheduled dosing, length of stay, and number of PRN doses administered depending on PRN treatment agent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>There were 86 infants in the methadone group and 52 in the morphine group. There were no significant differences in NOWS hospital outcomes between groups in adjusted models: transition to scheduled dosing (methadone 31.6% vs morphine 28.6%, adjusted odds ratio 1.21, 95% confidence interval [CI] 0.87\u20131.19), mean length of stay (methadone 15.5 vs morphine 14.3 days, adjusted risk ratio 1.06, 95% CI 0.80\u20131.41), and the mean number of PRN doses (methadone 2.3 vs morphine 3.4, adjusted risk ratio 0.65, 95% CI 0.41\u20131.02). There was an association with nonpharmacologic care practices and improved NOWS hospital outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>There were no significant differences in NOWS hospitalization outcomes based on pharmacologic agent type; nonpharmacologic care practices were most strongly associated with improved NOWS hospitalization outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006301","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T08:06:30Z","timestamp":1649664390000},"page":"530-538","source":"Crossref","is-referenced-by-count":12,"title":["Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy"],"prefix":"10.1542","volume":"12","author":[{"given":"Tierney M.","family":"Morrison","sequence":"first","affiliation":[{"name":"aDepartment of Newborn Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Dee L","family":"MacMillan","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, MassGen Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Melvin","sequence":"additional","affiliation":[{"name":"cCenter for Applied Pediatric Quality Analytics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Singh","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, Tufts Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Murzycki","sequence":"additional","affiliation":[{"name":"eDepartment of Newborn Medicine, Lowell General Hospital, Lowell, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia W","family":"Van Vleet","sequence":"additional","affiliation":[{"name":"fDepartment of Newborn Medicine, Baystate Franklin Medical Center, Greenfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rothstein","sequence":"additional","affiliation":[{"name":"gDepartment of Pediatrics, Baystate Medical Center, Springfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"hBoston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Gupta","sequence":"additional","affiliation":[{"name":"iDepartment of Newborn Medicine, Beth Israel Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, MassGen Hospital for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[{"name":"jDepartment of Pediatrics, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"issue":"5","key":"2023112014380064800_b1","doi-asserted-by":"crossref","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"2023112014380064800_b2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.clp.2019.08.012","article-title":"Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes","volume":"46","author":"MacMillan","year":"2019","journal-title":"Clin Perinatol"},{"issue":"10","key":"2023112014380064800_b3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/14767058.2017.1414180","article-title":"Nonpharmacological management of neonatal abstinence syndrome: a review of the literature","volume":"32","author":"Ryan","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"13","key":"2023112014380064800_b4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"2023112014380064800_b5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1891\/0730-0832.38.3.160","article-title":"Neonatal opioid withdrawal syndrome: a developmental care approach","volume":"38","author":"Piccotti","year":"2019","journal-title":"Neonatal Netw"},{"issue":"8","key":"2023112014380064800_b6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1542\/hpeds.2019-0089","article-title":"The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome","volume":"9","author":"Snowden","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"8","key":"2023112014380064800_b7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.6061\/clinics\/2016(08)11","article-title":"Metabolism and pharmacokinetics of morphine in neonates: a review","volume":"71","author":"Pacifici","year":"2016","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"2023112014380064800_b8","unstructured":"Lexicomp. Home: Lexicomp. Available at: online.lexi.com\/lco\/action\/login. Accessed October 17, 2021"},{"issue":"6","key":"2023112014380064800_b9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone--metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"issue":"6","key":"2023112014380064800_b10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pan.12385","article-title":"The pharmacokinetics of methadone and its metabolites in neonates, infants, and children","volume":"24","author":"Ward","year":"2014","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"2023112014380064800_b11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome","volume":"167","author":"Hall","year":"2015","journal-title":"J Pediatr"},{"issue":"7","key":"2023112014380064800_b12","doi-asserted-by":"crossref","first-page":"e197025","DOI":"10.1001\/jamanetworkopen.2019.7025","article-title":"Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis","volume":"2","author":"Yeoh","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023112014380064800_b13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2015.11.001","article-title":"Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2 years","volume":"92","author":"Kocek","year":"2016","journal-title":"Early Hum Dev"},{"issue":"6","key":"2023112014380064800_b14","doi-asserted-by":"crossref","first-page":"e20193861","DOI":"10.1542\/peds.2019-3861","article-title":"A quality improvement intervention to reduce postoperative opiate use in neonates","volume":"146","author":"Grabski","year":"2020","journal-title":"Pediatrics"},{"issue":"8","key":"2023112014380064800_b15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1542\/hpeds.2018-0165","article-title":"Standard fixed-schedule methadone taper versus symptom-triggered methadone approach for treatment of neonatal opioid withdrawal syndrome","volume":"9","author":"Wachman","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"8","key":"2023112014380064800_b16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1542\/hpeds.2018-0238","article-title":"Reduction in length of stay and morphine use for NAS with the \u201ceat, sleep, console\u201d method","volume":"9","author":"Blount","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"9","key":"2023112014380064800_b17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1542\/hpeds.2020-0032","article-title":"The Colorado hospitals substance exposed newborn quality improvement collaborative: standardization of care for opioid-exposed newborns shortens length of stay and reduces number of infants requiring opiate therapy","volume":"10","author":"Hwang","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"1","key":"2023112014380064800_b18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"key":"2023112014380064800_b19","unstructured":"Perinatal-Neonatal Quality Improvement Network of Massachusetts Website. Home: Perinatal-Neonatal Quality Improvement Network of Masschusetts. Available at: pnqinma.org. Accessed October 17, 2021"},{"issue":"6","key":"2023112014380064800_b20","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41372-021-00969-z","article-title":"Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database","volume":"41","author":"Singh","year":"2021","journal-title":"J Perinatol"},{"issue":"10","key":"2023112014380064800_b21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41372-020-0733-y","article-title":"A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts\u2019 PNQIN collaborative","volume":"40","author":"Wachman","year":"2020","journal-title":"J Perinatol"},{"issue":"8","key":"2023112014380064800_b22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome","volume":"38","author":"Wachman","year":"2018","journal-title":"J Perinatol"},{"issue":"2","key":"2023112014380064800_b23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.siny.2019.01.003","article-title":"Beyond the Finnegan scoring system: novel assessment and diagnostic techniques for the opioid-exposed infant","volume":"24","author":"Schiff","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1-2","key":"2023112014380064800_b24","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"6","key":"2023112014380064800_b25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1542\/hpeds.2016-0218","article-title":"Male sex associated with increased risk of neonatal abstinence syndrome","volume":"7","author":"Charles","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"7","key":"2023112014380064800_b26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2023112014380064800_b27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2023112014380064800_b28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpeds.2020.10.030","article-title":"Development and validation of a model to predict neonatal abstinence syndrome","volume":"229","author":"Patrick","year":"2021","journal-title":"J Pediatr"},{"key":"2023112014380064800_b29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.07.024","article-title":"Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity","volume":"192","author":"Wachman","year":"2018","journal-title":"Drug Alcohol Depend"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/5\/530\/1573230\/hpeds.2021-006301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/5\/530\/1573230\/hpeds.2021-006301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:38:53Z","timestamp":1700491133000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/5\/530\/186747\/Neonatal-Opioid-Withdrawal-Syndrome-A-Comparison"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006301","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}